Applied Materials Equity Method Investments increased by 14.8% to $4.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 85.0%, from $2.69B to $4.97B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 21.9% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.57B | $1.66B | $2.06B | $2.03B | $2.10B | $2.05B | $1.98B | $2.09B | $2.02B | $2.18B | $2.28B | $2.91B | $2.98B | $2.98B | $2.79B | $2.69B | $3.64B | $4.13B | $4.33B | $4.97B |
| QoQ Change | — | +5.7% | +23.9% | -1.4% | +3.8% | -2.6% | -3.3% | +5.5% | -3.1% | +7.6% | +4.8% | +27.6% | +2.5% | -0.1% | -6.5% | -3.6% | +35.4% | +13.6% | +4.7% | +14.8% |
| YoY Change | — | — | — | — | +34.0% | +23.5% | -3.6% | +3.1% | -3.7% | +6.4% | +15.2% | +39.4% | +47.4% | +36.9% | +22.2% | -7.7% | +22.0% | +38.6% | +55.3% | +85.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.